Charles River Laboratories International (MEX:CRL) Cyclically Adjusted FCF per Share: MXN128.26 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:CRL Charles River Laboratories International Inc MEX:CRL
51 GF Score
Price MXN4,720.00
GF Value MXN2,782.12
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Charles River Laboratories International Cyclically Adjusted FCF per Share?

Charles River Laboratories International MEX:CRL -1.97% 51 Cyclically Adjusted FCF per Share is MXN128.26 as of Jun. 2026. GuruFocus rates MEX:CRL with a GF Score™ of 51/100 and a GF Value™ of MXN2,782.12 (Significantly Overvalued). The stock has 9 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Charles River Laboratories International's adjusted free cash flow per share for the three months ended in Jun. 2026 was MXN54.003. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is MXN128.26 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Charles River Laboratories International's average Cyclically Adjusted FCF Growth Rate was 3.00% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 7.60% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 9.60% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 12.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Charles River Laboratories International was 17.70% per year. The lowest was 6.20% per year. And the median was 12.40% per year.

As of today (2026-08-16), Charles River Laboratories International's current stock price is MXN4720.00. Charles River Laboratories International's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was MXN128.26. Charles River Laboratories International's Cyclically Adjusted Price-to-FCF of today is 36.80.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Charles River Laboratories International was 77.15. The lowest was 11.90. And the median was 29.64.


Charles River Laboratories International  (MEX:CRL) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Charles River Laboratories International's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=4720.00/128.26
=36.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Charles River Laboratories International was 77.15. The lowest was 11.90. And the median was 29.64.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Charles River Laboratories International Cyclically Adjusted FCF per Share Related Terms


Charles River Laboratories International Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Charles River Laboratories International's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Charles River Laboratories International Cyclically Adjusted FCF per Share Chart

Charles River Laboratories International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 138.16 122.54 177.57 142.03

Charles River Laboratories International Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 230.51 228.48 142.03 164.62 128.26

MEX:CRL vs RVTY, ICLR, QGEN: Cyclically Adjusted FCF per Share Comparison

For the Diagnostics & Research subindustry, Charles River Laboratories International's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Charles River Laboratories International Cyclically Adjusted Price-to-FCF vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Charles River Laboratories International's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Charles River Laboratories International's Cyclically Adjusted Price-to-FCF falls into.


MEX:CRL
51GF Score
Charles River Laboratories International Inc MEX:CRL
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Charles River Laboratories International Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Charles River Laboratories International's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=54.003/333.9520*333.9520
=54.003

Current CPI (Jun. 2026) = 333.9520.

Charles River Laboratories International Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 24.988 241.428 34.564
201612 40.281 241.432 55.717
201703 6.858 243.801 9.394
201706 31.708 244.955 43.228
201709 14.054 246.819 19.015
201712 38.421 246.524 52.047
201803 12.027 249.554 16.094
201806 41.131 251.989 54.509
201809 35.951 252.439 47.560
201812 28.735 251.233 38.196
201903 -0.734 254.202 -0.964
201906 40.525 256.143 52.835
201909 47.924 256.759 62.332
201912 44.168 256.974 57.399
202003 20.118 258.115 26.029
202006 62.249 257.797 80.638
202009 65.841 260.280 84.477
202012 19.580 260.474 25.103
202103 56.910 264.877 71.751
202106 54.350 271.696 66.804
202109 47.533 274.310 57.868
202112 51.854 278.802 62.111
202203 8.599 287.504 9.988
202206 26.135 296.311 29.455
202209 23.686 296.808 26.650
202212 55.331 296.797 62.258
202303 0.879 301.836 0.973
202306 26.895 305.109 29.437
202309 47.086 307.789 51.088
202312 47.167 306.746 51.350
202403 16.245 312.332 17.369
202406 54.434 314.175 57.861
202409 81.334 315.301 86.145
202412 33.998 315.605 35.974
202503 45.208 319.799 47.209
202506 64.642 322.561 66.925
202509 66.155 324.800 68.019
202512 21.428 324.054 22.083
202603 -5.463 330.213 -5.525
202606 54.003 333.952 54.003

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of MXN128.26 mean?
Charles River Laboratories International (MEX:CRL) has a Cyclically Adjusted FCF per Share of MXN128.26 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Charles River Laboratories International and its competitors.
Is Charles River Laboratories International's Cyclically Adjusted FCF per Share too high?
Charles River Laboratories International's current Cyclically Adjusted FCF per Share is MXN128.26. Overall, Charles River Laboratories International has a GF Score™ of 51/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Charles River Laboratories International's Cyclically Adjusted FCF per Share compare to RVTY and ICLR?
Charles River Laboratories International's Cyclically Adjusted FCF per Share of MXN128.26 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted FCF per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Charles River Laboratories International and its competitors. Charles River Laboratories International's current Cyclically Adjusted FCF per Share is MXN128.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Charles River Laboratories International stock overvalued right now?
Based on GuruFocus' analysis, Charles River Laboratories International (MEX:CRL) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN2,782.12, compared to a current price of MXN4,720.00 — trading 69.7% above its estimated fair value. The current Cyclically Adjusted FCF per Share is MXN128.26. Charles River Laboratories International's overall GF Score™ is 51/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Charles River Laboratories International (MEX:CRL), the current Cyclically Adjusted FCF per Share is MXN128.26 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Charles River Laboratories International (MEX:CRL) Overvalued in 2026?

Based on GuruFocus' analysis, Charles River Laboratories International stock appears to be overvalued. The current stock price of MXN4,720.00 is trading 69.7% above its estimated GF Value™ of MXN2,782.12. GuruFocus considers Charles River Laboratories International to be Significantly Overvalued.

Key valuation signals for MEX:CRL:

  • Cyclically Adjusted FCF per Share: MXN128.26
  • GF Value™: MXN2,782.12 vs. price of MXN4,720.00 (69.7% above fair value)
  • GF Score™: 51/100 with 9 warning signs

No single metric tells the full story. See the MEX:CRL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Charles River Laboratories International Business Description

Other Exchanges CRL:USARV6:Germany
Address 251 Ballardvale Street, Wilmington, MA, USA, 01887
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
51GF Score

Get the complete analysis for MEX:CRL

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN4,720.00
Price
MXN2,782.12
GF Value